Global University Venturing

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

Founded at Imperial Collge London, Sprout three years ago, Sprout.ai has now secured $11m in a series A round led by Octopus Ventures.

Solid-state battery developer Solid Power secured a $130 series B round co-led by its potential customers from the automotive sector BMW and Ford Motor Company.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Advancing Harvard Medical School research, Dyno Therapeutics has raised $100m to advance its gene therapies based on AAV.

Talaris has raised $150m in an initial public offering almost two decades after being spun out of University of Louisville as Regenerx.

Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.

UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.

A decade or more after setting up the golden age of corporate venturing units were set up with a focus on life sciences and healthcare, such as US-listed conglomerate Alphabet’s GV (formerly known as Google Ventures) and US-listed drugs company Merck’s Global Health Innovation Fund (GHIF), and the returns have surpassed many expectations.